Transgenesis: an approach to its risks and benefits
Keywords:
transgenesis, organisms, genetically modifiedAbstract
Introduction: transgenesis is one of the most recent and controversial technologies of recent times. It consists of the construction of new combinations of genetic material by inserting a deoxyribonucleic acid of interest in a vector that allows it to replicate, remain in the cells of the recipient organism and express itself.Objective: to identify the main risks and benefits of transgenesis.
Methods: scientific literature was reviewed in the period from 2016 to 2020. Academic Google, Pubmed and SciELO databases were used. Seventy-seven articles were reviewed, 30 of which met the inclusion criteria.
Results: the main risks and benefits of transgenesis were identified with respect to plants (transgenic foods), animals and humans. Proponents of this technology argue that transgenic production would favour crop and livestock production and the possibility of medicines and medical products; opponents identify a number of risks to such important legal assets as health (individual and collective), the environment and biodiversity. The negative impact of the patents of the large transnationals is added.
Conclusions: Biotechnology has allowed scientific-technical progress and has sought a better life, but not making a reflective and controlled use of this knowledge could put our lives and those of future generations at risk. Transgenesis cannot be catalogued as good or bad, it is only a tool, everything depends on the controlled, rational, sustainable and conscious use that is given to it.
Downloads
References
1. Mora Sánchez JM. Algunas implicaciones éticas y jurídicas de los transgénicos. Opinión Jurídica [Internet]. 2003 [citado 08/01/2020];2(3):87-96. Disponible en: https://revistas.udem.edu.co/index.php/opinion/article/view/1337/1359
2. Tormo Garrido A. Fundamentos de la transgénesis. Reduca [Internet]. 2012 [citado 08/01/2020];5(4):1-30. Disponible en: http://www.revistareduca.es/index.php/biologia/article/viewFile/978/984
3. Montanari AL. Estudio del proceso de apropiación por patentes de la tecnología de transgénesis vegetal en argentina [tesis de Maestría]. Argentina: FLACSO; 2014 [citado 08/01/2020]. Disponible en: https://flacso.org.ar/wp-content/uploads/2013/07/Montanari_Ana-C09-10.pdf
4. Capó Martí MA. Aspectos ecogenéticos y legislativos aplicados a la transgénesis de animales y alimentos [tesis doctoral]. España: Universidad Complutense de Madrid; 2016 [citado 08/01/2020]. Disponible en: https://eprints.ucm.es/38902/1/T37692.pdf
5. Aparisi Miralles A. Alimentos transgénicos y derecho humano a la salud. Cuad Bioét [Internet]. 2004 [citado 08/01/2020];15(53):59-76. Disponible en: https://core.ac.uk/download/pdf/324039903.pdf
6. Nogueira Furtado R. Gene editing: the risks and benefits of modifying human DNA. Revbioét [Internet]. 2019 Apr-Jun [citado 08/01/2020];27(2):223-33. Disponible en: https://www.scielo.br/scielo.php?pid=S1983-80422019000200223&script=sci_arttext&tlng=en. https://doi.org/10.1590/1983-80422019272304
7. Fuentes F, Reynolds E, Lewellis SW, Venkiteswara G, Knaut H. A plasmid set for efficient bacterial artificial chromosome (BAC) transgenesis in Zebrafish. G3: Genes, Genomes, Genetics [Internet]. 2016 [citado 08/01/2020];6(4):829–834. Disponible en: https://www.g3journal.org/content/6/4/829. https://doi.org/10.1534/g3.115.026344
8. Lacadena Calero JR. Historia “Nobelada” de la Genética (1900-2016). Concepto y Método. Segunda Addenda [Internet]. Madrid: Real Academia Nacional de Farmacia; 2016. Disponible en: http://segenética.es/jrl/Historia-nobelada-JRLacadena.pdf
9. Rousselière D, Rousselière S. Is biotechnology (more) acceptable when it enables a reduction in phytosanitary treatments? A European comparison of the acceptability of transgenesis and cisgenesis. PLoS One [Internet]. 2017 [citado 08/01/2020];12(9):e0183213. Disponible en: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0183213. https://doi.org/10.1371/journal.pone.0183213
10. Héctor Ardisana E, Pérez Álvarez S, Moreira Macías R, Millet Gaínza B. Perspectivas futuras e impacto social de las biotecnologías vegetales. Alternativas [Internet]. 2016 [citado 08/01/2020];17(2):44-51. Disponible en: https://dialnet.unirioja.es/descarga/articulo/7371191.pdf. http://dx.doi.org/10.23878/alternativas.v17i2.116
11. Gómez-Tatay L, Aznar J. CRISPR-Cas9. El mayor avance en técnicas de edición genética requiere una reflexión Ética. Cuad Bioet [Internet]. 2019 [citado 08/01/2020];30(99):171-185. Disponible en: http://aebioetica.org/revistas/2019/30/99/171.pdf
12. Tonelli F, Lacerda S, Tonelli F, Costa G, Franca LR, Resende R. Progress and biotechnological prospects in fish transgenesis. Biotechnol Adv [Internet]. 2017 Nov [citado 08/01/2020];35(6):832-844. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0734975017300617. https://doi.org/10.1016/j.biotechadv.2017.06.002
13. Gutman GE, Lavarello P. Desarrollo reciente de la moderna biotecnología en el sector de la salud humana. Argentina: CEUR-CONICET; 2010. Disponible en: http://ceur-conicet.gov.ar/archivos/publicaciones/MBenSHDocumento2.pdf
14. Garrels W, Talluri TR, Apfelbaum R, Carratalá YP, Bosch P, Pötzsch K, et al. One-step multiplex transgenesis via sleeping beauty transposition in Cattle. Sci Rep [Internet]. 2016 [citado 08/01/2020];6:21953. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764937/. https://dx.doi.org/10.1038/srep21953
15. Bevacqua RJ, Fernández-Martin R, Canel NG, Gibbons A, Texeira D, Lange F, et al. Assessing Tn5 and Sleeping Beauty for transposition altransgenesis by cytoplasmic injection into bovine and ovine zygotes. PLoS One [Internet]. 2017 [citado 08/01/2020];12(3):e0174025. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354444/. https://dx.doi.org/10.1371/journal.pone.0174025
16. Marfany G. Interrogantes y retos actuales de la edición genética. Rev Bioét Der [Internet]. 2019 [citado 08/01/2020];47:17-31. Disponible en: http://scielo.isciii.es/pdf/bioetica/n47/1886-5887-bioetica-47-00017.pdf
17. Laugsch M, Sergiy Velychko M, Richter C, Zimmer A, Klink B, Schröck E, et al. Functional restoration of gp91phox-oxidase activity by BAC transgenesis and gene targeting in X-linked chronic granulomatous disease iPSCs. Mol Ther [Internet]. 2016 Apr [citado 08/01/2020];24(4):812–822. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886927/
18. Gude NA, Firouzi F, BroughtonKM, Ilves K, NguyenKP, PayneCR, et al. Cardiac c-kit biology revealed by inducible transgenesis. Rev Circ Res [Internet]. 2018 Jun [citado 08/01/2020];123(1):57–72. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192707/. https://doi.org/10.1161/CIRCRESAHA.117.311828
19. Astell KR, Sieger D. Zebrafish in vivo models of cancer and metastasis. Cold Spring Harb Perspect Med [Internet]. 2020 Aug [citado 01/09/2020];10(8):a037077. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31615862/
20. Iver A, Subramanian L, Tole S. Organotypic explants of the embryonic rodent hippocampus: An accessible system for transgenesis. Bio Protoc [Internet]. 2018 Mar [citado 08/01/2020];8(6):e2764. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884433/. https://dx.doi.org/10.21769/BioProtoc.2764
21. López P, Giles K, Dugger B, Oehler A, Condello C, Krejciova Z, et al. A novel vector fortransgenesis in de rat CNS. Acta Neuropathol Commun [Internet]. 2017 [citado 08/01/2020];5(84):1-14. Disponible en: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-017-0484-y
22. Bachmann Fuentes RI. Evaluación de riesgos derivados de los organismos modificados genéticamente y la adopción de medidas de emergencia en el marco de la Unión Europea. RCDA [Internet]. 2019 [citado 08/01/2020];10(1):1-45. Disponible en: https://www.raco.cat/index.php/rcda/article/view/359764/451787
23. Reyes Rodríguez M. Transgénesis en plantas: miradas diferentes. Rev Órbita Científica [Internet]. 2018 [citado 08/01/2020];24(102):[aprox. 6 p.]. Disponible en: http://revistas.ucpejv.edu.cu/index.php/rOrb/article/view/484/716
24. Oviedo-Bolaños K, García-González J, Solano-González S, Martínez-Debat C, Sancho-Blanco C, Umaña-Castro R. Detección de p35S indicador transgenicidad en alimentos y algodón. Agron Mesoam [Internet]. 2020 [citado 01/09/2020];31(1):209-221. Disponible en: http://www.mag.go.cr/rev_meso/v31n01_209.pdf
25. Casquier J, Ortiz R. Las semillas transgénicas: ¿un debate bioético? Derecho PUCP [Internet]. 2012 [citado 01/09/2020];(69):281-300. Disponible en: https://www.corteidh.or.cr/tablas/r31737.pdf
26. Rojas Arias AC. Estudio del efecto del genotipo vegetal, cepa de Agrobacterium tumefaciens, y casete de expresión, en la expresión de la tolerancia a glifosato en variedades colombianas de soya [tesis doctoral]. Colombia: Universidad Nacional de Colombia;2017 [citado 08/01/2020]. Disponible en: http://bdigital.unal.edu.co/59344/1/1032360429.2017.pdf
27. Lopez Baroni M. Las tres Europas ante la encrucijada genómica. Rev Bio Der [Internet]. 2019 [citado 08/01/2020];47:77-92. Disponible en: http://www.mag.go.cr/rev_meso/v31n01_209.pdf. https://doi.org/10.1186/s40478-017-0484-y
28. González Cruz J. La industria transgénica: Expropiación de la vida. Nómadas [Internet]. 2011 [citado 08/01/2020];30(2):217-232. Disponible en: https://revistas.ucm.es/index.php/NOMA/article/view/36585/35418
29. Peña Ahues NL, Gutiérrez Cárcamo FM, Alvayero Henríquez GM, González Batarse RI, Garzona Jiménez EA. Consumo y regulación de alimentos transgénicos contaminados con Glifosato y su repercusión en la salud. Rev SCientifica [Internet]. 2017[citado 08/01/2020];15(1):35-39. Disponible en: https://redib.org/Record/oai_articulo1443585-consumo-y-regulaci%C3%B3n-de-alimentos-transg%C3%A9nicos-contaminados-con-glifosato-y-su-repercusi%C3%B3n-en-la-salud
30. Serpa I, Calvo K, Torres Monserrat V, Carbonaro M, Martínez MA, Rodríguez M, et al. Efectos del glifosato sobre el endometrio de ratas hembras. Reproducción [Internet]. 2015 [citado 08/01/2020];30(1):14-25. Disponible en: http://www.samer.org.ar/revista/numeros/2015/Numero_1/6_7_8.pdf
Downloads
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms:
- Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
- Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
- Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).